Advanced practice providers (APPs) are playing a critical role in the delivery of anti-amyloid therapies for Alzheimer’s disease, according to healthcare professionals. They are responsible for managing the complex logistics of treatment, including scheduling imaging scans, infusion appointments, and necessary follow-up care.
Patient safety is paramount during these therapies. APPs are implementing rigorous monitoring protocols to quickly identify and address potential infusion reactions, track lab results, and monitor for any changes in a patient’s condition. regular dialogue with patients is also key, helping to ensure they understand the treatment plan and promptly report any concerns.
This coordinated approach not only improves the efficiency of Alzheimer’s care delivery but also builds trust with patients navigating a challenging treatment process. APPs function as central organizers within the healthcare teams providing this advanced care.
